A Combination of Sorafenib, Capecitabine and Oxaliplatin (SECOX) as Neoadjuvant Therapy in Patients With Locally Advanced Hepatocellular Carcinoma: A Phase II Study
Latest Information Update: 14 Apr 2020
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 08 Apr 2020 Status changed from recruiting to completed.
- 11 Jul 2018 New trial record